BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 005165
(710 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 42/97 (43%), Positives = 59/97 (60%), Gaps = 3/97 (3%)
Query: 596 QQFTYSEIVDITNNF--HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTE 652
++F+ E+ ++NF ILG+GGFG VY G LADG+ VA+K L QG + QF+TE
Sbjct: 26 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+++ HRNL L G+C LVY YMA G++
Sbjct: 86 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 43/101 (42%), Positives = 60/101 (59%), Gaps = 3/101 (2%)
Query: 596 QQFTYSEIVDITNNF--HRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK-QFRTE 652
++F+ E+ ++NF ILG+GGFG VY G LADG VA+K L +QG + QF+TE
Sbjct: 18 KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 653 AQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+++ HRNL L G+C LVY YMA G++ L
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 75.5 bits (184), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 43/96 (44%), Positives = 65/96 (67%), Gaps = 2/96 (2%)
Query: 602 EIVDITNNF-HRIL-GKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
++ + TNNF H+ L G G FG VY G L DG++VA+K + SSQG ++F TE + L
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFG 695
H +L SL+G+C++ + L+Y+YM GNLK++L+G
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 43/96 (44%), Positives = 65/96 (67%), Gaps = 2/96 (2%)
Query: 602 EIVDITNNF-HRIL-GKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV 659
++ + TNNF H+ L G G FG VY G L DG++VA+K + SSQG ++F TE + L
Sbjct: 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLFG 695
H +L SL+G+C++ + L+Y+YM GNLK++L+G
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 37/104 (35%), Positives = 63/104 (60%), Gaps = 13/104 (12%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
F++ E+ ++TNNF +G+GGFG VY GY+ + + VA+K L+A ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+QF E +++ + H NL L+G+ +DG ++ LVY YM G+L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 37/104 (35%), Positives = 63/104 (60%), Gaps = 13/104 (12%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
F++ E+ ++TNNF +G+GGFG VY GY+ + + VA+K L+A ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+QF E +++ + H NL L+G+ +DG ++ LVY YM G+L
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 37/104 (35%), Positives = 63/104 (60%), Gaps = 13/104 (12%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
F++ E+ ++TNNF +G+GGFG VY GY+ + + VA+K L+A ++ +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+QF E +++ + H NL L+G+ +DG ++ LVY YM G+L
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 36/104 (34%), Positives = 60/104 (57%), Gaps = 13/104 (12%)
Query: 598 FTYSEIVDITNNFHR--------ILGKGGFGTVYHGYLADGSEVAIKMLSA----SSSQG 645
F++ E+ ++TNNF G+GGFG VY GY+ + + VA+K L+A ++ +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 646 PKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+QF E ++ + H NL L+G+ +DG ++ LVY Y G+L
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + + + F EA+++M++ H L L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV+E+M +G L YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYL 91
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + + + F EA+++M++ H L L
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV+E+M +G L YL
Sbjct: 69 GVCLEQAPICLVFEFMEHGCLSDYL 93
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + S F EA+++M++ H L L
Sbjct: 30 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV+E+M +G L YL
Sbjct: 89 GVCLEQAPICLVFEFMEHGCLSDYL 113
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + + + F EA+++M++ H L L
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV+E+M +G L YL
Sbjct: 69 GVCLEQAPICLVFEFMEHGCLSDYL 93
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + + + F EA+++M++ H L L
Sbjct: 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV+E+M +G L YL
Sbjct: 72 GVCLEQAPICLVFEFMEHGCLSDYL 96
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
LG+G FG V+ H L + + VA+K L +S + F+ EA+LL + H+++
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
G C +G + +V+EYM +G+L ++L
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFL 111
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
LG+G FG V+ H L + + VA+K L +S + F+ EA+LL + H+++
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
G C +G + +V+EYM +G+L ++L
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFL 105
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F R LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 17 FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ E++ YG+L++YL
Sbjct: 77 VKYKGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 614 LGKGGFGTVY----HGYLADGSE--VAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
LG+G FG V+ H L + + VA+K L +S + F+ EA+LL + H+++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
G C +G + +V+EYM +G+L ++L
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFL 134
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 612 RILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
R LG+G FG V+ D VA+K L + K F+ EA+LL + H ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
G C DG + +V+EYM +G+L ++L
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 55.8 bits (133), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 612 RILGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
R LG+G FG V+ D VA+K L +S K F EA+LL + H ++
Sbjct: 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
G C +G + +V+EYM +G+L ++L
Sbjct: 79 KFYGVCVEGDPLIMVFEYMKHGDLNKFL 106
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 12/112 (10%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSS 643
GS D QF + F + LGKG FG+V + L D G VA+K L S+
Sbjct: 1 GSEDRDPTQFEERHL-----KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 55
Query: 644 QGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
+ + F E ++L + H N+ G C G N+ L+ EY+ YG+L+ YL
Sbjct: 56 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 55.8 bits (133), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + +G G FG V+ GY + +VAIK + + + F EA+++M++ H L L
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + + LV E+M +G L YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYL 94
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 13 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 73 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 18 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 78 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 593 SDNQQFTYSEIVDITNNFHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPK 647
SD QF + F + LGKG FG+V + L D G VA+K L S+ + +
Sbjct: 2 SDPTQFEERHL-----KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 56
Query: 648 QFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
F E ++L + H N+ G C G N+ L+ EY+ YG+L+ YL
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 12 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 72 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 593 SDNQQFTYSEIVDITNNFHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPK 647
SD QF + F + LGKG FG+V + L D G VA+K L S+ + +
Sbjct: 2 SDPTQFEERHL-----KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 56
Query: 648 QFRTEAQLLMRVHHRNLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
F E ++L + H N+ G C G N+ L+ EY+ YG+L+ YL
Sbjct: 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 17 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 77 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 19 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 79 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 20 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 80 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 21 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 81 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYL 90
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 11 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 70 GVCTKQRPIFIITEYMANGCLLNYL 94
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 15 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 75 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYL---ADGSE---VAIKMLSAS 641
E L + ++Q EI F LG+ FG VY G+L A G + VAIK L
Sbjct: 8 EMPLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-D 66
Query: 642 SSQGP--KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++GP ++FR EA L R+ H N+ L+G + +++ Y ++G+L ++L
Sbjct: 67 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 32 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 92 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 71 GVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 71 GVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 610 FHRILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNL 664
F + LGKG FG+V + L D G VA+K L S+ + + F E ++L + H N+
Sbjct: 32 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 665 ASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
G C G N+ L+ EY+ YG+L+ YL
Sbjct: 92 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F + LG G FG V +G +VAIKM+ S +F EA+++M + H L L
Sbjct: 18 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 669 GYCNDGGNVGLVYEYMAYGNLKQYL 693
G C + ++ EYMA G L YL
Sbjct: 77 GVCTKQRPIFIITEYMANGCLLNYL 101
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 609 NFHRILGKGGFGTVYHGYLADG-------SEVAIKML-SASSSQGPKQFRTEAQLLMRVH 660
+ R +G+G FG V+ A G + VA+KML +S+ F+ EA L+
Sbjct: 50 EYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 108
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ N+ L+G C G + L++EYMAYG+L ++L
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 52 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 142
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 51 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 141
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 25 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 85 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 115
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 32 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 92 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 122
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 34 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 94 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 124
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 38 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 98 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 128
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G FG VY G S VA+K L + + ++F EA ++ +
Sbjct: 9 ERTDITMK-HK-LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 66 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 33 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 93 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 123
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 52.4 bits (124), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 31 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 91 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 121
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 52.4 bits (124), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 609 NFHRILGKGGFGTVYHGYLADGS----EVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRN 663
+F+ ++G+G FG VYHG L D A+K L+ + G QF TE ++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 664 LASLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+ SL+G C G+ +V YM +G+L+ ++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 609 NFHRILGKGGFGTVYHGYL---ADGSE---VAIKMLSASSSQGP--KQFRTEAQLLMRVH 660
F LG+ FG VY G+L A G + VAIK L ++GP ++FR EA L R+
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQ 70
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H N+ L+G + +++ Y ++G+L ++L
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 103
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 12 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 69 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 101
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 16 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 73 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 105
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 16 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 9 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 66 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 98
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 12 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 69 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 101
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 13 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 16 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 9 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 66 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 16 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 24 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 80
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 81 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 113
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 15 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 71
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 104
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 13 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 16 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 73 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 11 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 13 ERTDITMK-HK-LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 70 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 43/91 (47%), Gaps = 5/91 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSEVAIKMLSASS----SQGPKQFRTEAQLLMRVHHRNL 664
I+G GGFG VY + G EVA+K SQ + R EA+L + H N+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYLFG 695
+L G C N+ LV E+ G L + L G
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSG 99
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 23 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 82
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 83 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 16 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 75
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 76 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 126
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 31 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 31 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 31 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT H+ LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 30 ERTDITMK-HK-LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 86
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C +V EYM YGNL YL
Sbjct: 87 HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL 119
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFGTVYHG-YLADGSE-----VAIKMLSASSSQ 644
D Q Y+E + N F + LG G FG V G E VA+KML +++
Sbjct: 31 DPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K+ +E +++ + H N+ +L+G C GG V ++ EY YG+L +L
Sbjct: 91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK 647
+G++ D+ + ++ N +G G FGTV+ GS+VA+K+L +
Sbjct: 24 QGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER 77
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+F E ++ R+ H N+ +G N+ +V EY++ G+L + L
Sbjct: 78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPK 647
+G++ D+ + ++ N +G G FGTV+ GS+VA+K+L +
Sbjct: 24 QGAMDGDDMDIPWCDL-----NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER 77
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+F E ++ R+ H N+ +G N+ +V EY++ G+L + L
Sbjct: 78 VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 218 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 274
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 215 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 271
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 272 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 304
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 49.7 bits (117), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGS-EVAIKMLSASSSQGPKQFRTEAQLLMRVH 660
E DIT LG G +G VY G S VA+K L + + ++F EA ++ +
Sbjct: 257 ERTDIT--MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 313
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H NL L+G C ++ E+M YGNL YL
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 346
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 49.3 bits (116), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQGPK---QFRTEAQLLMRVHHRN 663
++LG G FGTVY G E VAIK+L+ ++ GPK +F EA ++ + H +
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 78
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L L+G C + LV + M +G L +Y+
Sbjct: 79 LVRLLGVCL-SPTIQLVTQLMPHGCLLEYV 107
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-----VAIKMLSASSSQGPK---QFRTEAQLLMRVHHRN 663
++LG G FGTVY G E VAIK+L+ ++ GPK +F EA ++ + H +
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPH 101
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L L+G C + LV + M +G L +Y+
Sbjct: 102 LVRLLGVCLS-PTIQLVTQLMPHGCLLEYV 130
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 609 NFHRILGKGGFGTVY----HGYLADGS--EVAIKMLSASSSQGPKQ-FRTEAQLLMRV-H 660
F ++LG G FG V +G G +VA+KML + ++ +E +++ ++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H N+ +L+G C G + L++EY YG+L YL
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 75 -EPIXIVTEYMSKGSLLDFLKG 95
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHGYL------ADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V VA+KML ++ K TE ++L + HH N+
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 666 SLVGYC-NDGGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ EY YGNL YL
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYL 123
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVTEYMSKGSLLDFLKG 105
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
N + LG+G FG V A VA+KML ++ + +E ++L+ + H
Sbjct: 31 NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
H N+ +L+G C GG + ++ E+ +GNL YL
Sbjct: 91 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 78 -EPIYIVTEYMSKGSLLDFLKG 98
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
N + LG+G FG V A VA+KML ++ + +E ++L+ + H
Sbjct: 30 NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
H N+ +L+G C GG + ++ E+ +GNL YL
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 76 -EPIYIVTEYMSKGSLLDFLKG 96
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 74 -EPIYIVTEYMSKGSLLDFLKG 94
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVIEYMSKGSLLDFLKG 105
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVIEYMSKGSLLDFLKG 105
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKG 271
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V G +VA+KM+ S +F EAQ +M++ H L G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ +V EY++ G L YL
Sbjct: 75 EYPIYIVTEYISNGCLLNYL 94
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 609 NFHRILGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
N + LG+G FG V A VA+KML ++ + +E ++L+ + H
Sbjct: 30 NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 661 HRNLASLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
H N+ +L+G C GG + ++ E+ +GNL YL
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKG 271
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVTEYMSKGSLLDFLKG 105
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVTEYMSKGSLLDFLKG 105
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 85 -EPIYIVCEYMSKGSLLDFLKG 105
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 334 -EPIYIVTEYMSKGSLLDFLKG 354
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY + ++VA+K L + + F EA L+ + H L L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYMA G+L +L
Sbjct: 80 EEPIYIITEYMAKGSLLDFL 99
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 606 ITNNFHRILGKGGFGTVYHGYLADGS----EVAIKMLS-ASSSQGPKQFRTEAQLLMRVH 660
+ + R++GKG FG VYHG D + + AIK LS + Q + F E L+ ++
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 661 HRNLASLVG-YCNDGGNVGLVYEYMAYGNLKQYL 693
H N+ +L+G G ++ YM +G+L Q++
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 251 -EPIYIVGEYMSKGSLLDFLKG 271
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 44/82 (53%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G+L +L G
Sbjct: 252 -EPIYIVTEYMSKGSLLDFLKG 272
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 20 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 80 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 108
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 46.6 bits (109), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM G+L +L G
Sbjct: 82 -EPIYIVTEYMNKGSLLDFLKG 102
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 46.2 bits (108), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G L +L G
Sbjct: 85 -EPIYIVMEYMSKGCLLDFLKG 105
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 11/94 (11%)
Query: 612 RILGKGGFGTVYHGYL--ADGS--EVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLA 665
+ILG+G FG+V G L DG+ +VA+K L SS + ++F +EA + H N+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 666 SLVGYCNDGGNVGL-----VYEYMAYGNLKQYLF 694
L+G C + + G+ + +M YG+L YL
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL 133
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM G+L +L G
Sbjct: 82 -EPIYIVTEYMNKGSLLDFLKG 102
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 89 -EPIYIITEYMENGSLVDFL 107
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 86 -EPIYIITEYMENGSLVDFL 104
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 82 -EPIYIITEYMENGSLVDFL 100
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 85 EP-IYIITEYMENGSLVDFL 103
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 46.2 bits (108), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 86 EP-IYIITEYMENGSLVDFL 104
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 80 -EPIYIITEYMENGSLVDFL 98
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG+G FG V+ G + VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 674 GGNVGLVYEYMAYGNLKQYLFG 695
+ +V EYM+ G L +L G
Sbjct: 85 -EPIYIVTEYMSKGCLLDFLKG 105
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 81 -EPIYIITEYMENGSLVDFL 99
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 80 -EPIYIITEYMENGSLVDFL 98
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 46.2 bits (108), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 23 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 88 -EPIYIITEYMENGSLVDFL 106
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 45.8 bits (107), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 80 -EPIYIITEYMENGSLVDFL 98
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 24 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 84 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 112
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 75 -EPIYIITEYMENGSLVDFL 93
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 88 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 116
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 19/95 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
+ LG+G FG T +H GY + VA+KML ++S P + R +E +L +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
V+H ++ L G C+ G + L+ EY YG+L+ +L
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 90 -EPIYIITEYMENGSLVDFL 108
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 45.8 bits (107), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 19/95 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
+ LG+G FG T +H GY + VA+KML ++S P + R +E +L +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
V+H ++ L G C+ G + L+ EY YG+L+ +L
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 19/95 (20%)
Query: 612 RILGKGGFG-----TVYH-----GYLADGSEVAIKMLSASSSQGPKQFR---TEAQLLMR 658
+ LG+G FG T +H GY + VA+KML ++S P + R +E +L +
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGY----TTVAVKMLKENAS--PSELRDLLSEFNVLKQ 82
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
V+H ++ L G C+ G + L+ EY YG+L+ +L
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 76 -EPIYIITEYMENGSLVDFL 94
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNL 664
R LG+G FG VY G D + VA+K ++ S+S + +F EA ++ ++
Sbjct: 22 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G + G +V E MA+G+LK YL
Sbjct: 82 VRLLGVVSKGQPTLVVMELMAHGDLKSYL 110
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 9/89 (10%)
Query: 614 LGKGGFGTVYHG------YLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRNLA 665
LG+G FG V A VA+KML ++ + +E ++L+ + HH N+
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 666 SLVGYCND-GGNVGLVYEYMAYGNLKQYL 693
+L+G C GG + ++ E+ +GNL YL
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 45.4 bits (106), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 82 RLLGICLT-STVQLIMQLMPFGXLLDYV 108
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/119 (28%), Positives = 55/119 (46%), Gaps = 17/119 (14%)
Query: 588 EGSLKSDNQQFTYSEIVDITNNFH-------RILGKGGFGTVYHGYLADGS-----EVAI 635
+G++ SD Q ++ T H +++G G FG VY G L S VAI
Sbjct: 23 QGAMGSDPNQ----AVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78
Query: 636 KMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
K L A ++ + F EA ++ + H N+ L G + + ++ EYM G L ++L
Sbjct: 79 KTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
+ +GKG FG V G G++VA+K + ++ + F EA ++ ++ H NL L+G
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
+ G + +V EYMA G+L YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL 91
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
+ +GKG FG V G G++VA+K + ++ + F EA ++ ++ H NL L+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
+ G + +V EYMA G+L YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL 278
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
D Q Y + N F + LG G FG T Y +D + VA+KML S+
Sbjct: 24 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 83
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ +E ++L + +H N+ +L+G C GG ++ EY YG+L +L
Sbjct: 84 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 134
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 85 RLLGICLT-STVQLIMQLMPFGCLLDYV 111
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 1/80 (1%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ GY + ++VA+K L + + F EA L+ + H L L
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ E+MA G+L +L
Sbjct: 79 EEPIYIITEFMAKGSLLDFL 98
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLITQLMPFGXLLDYV 107
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 85 RLLGICLT-STVQLIMQLMPFGCLLDYV 111
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 82 RLLGICLT-STVQLIMQLMPFGCLLDYV 108
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
F ++G+G FG V + DG + AIK M +S + F E ++L ++ HH N+
Sbjct: 19 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+L+G C G + L EY +GNL +L
Sbjct: 79 INLLGACEHRGYLYLAIEYAPHGNLLDFL 107
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
F ++G+G FG V + DG + AIK M +S + F E ++L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+L+G C G + L EY +GNL +L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFL 117
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAI-----KMLSASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G +V I ++ A+S + K+ EA ++ V + ++
Sbjct: 55 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 115 RLLGICLT-STVQLITQLMPFGCLLDYV 141
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLIMQLMPFGCLLDYV 107
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
+ +GKG FG V G G++VA+K + ++ + F EA ++ ++ H NL L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
+ G + +V EYMA G+L YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL 106
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 83 RLLGICLT-STVQLIMQLMPFGCLLDYV 109
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 83 RLLGICLT-STVQLIMQLMPFGCLLDYV 109
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 47/83 (56%), Gaps = 4/83 (4%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY- 670
+ +GKG FG V G G++VA+K + ++ + F EA ++ ++ H NL L+G
Sbjct: 18 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
+ G + +V EYMA G+L YL
Sbjct: 75 VEEKGGLYIVTEYMAKGSLVDYL 97
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
D Q Y + N F + LG G FG T Y +D + VA+KML S+
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ +E ++L + +H N+ +L+G C GG ++ EY YG+L +L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 31 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 91 RLLGICLT-STVQLITQLMPFGCLLDYV 117
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 84 RLLGICLT-STVQLIMQLMPFGCLLDYV 110
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
D Q Y + N F + LG G FG T Y +D + VA+KML S+
Sbjct: 26 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 85
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ +E ++L + +H N+ +L+G C GG ++ EY YG+L +L
Sbjct: 86 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 136
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 610 FHRILGKGGFGTVYHGYLA-DG--SEVAIK-MLSASSSQGPKQFRTEAQLLMRV-HHRNL 664
F ++G+G FG V + DG + AIK M +S + F E ++L ++ HH N+
Sbjct: 26 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+L+G C G + L EY +GNL +L
Sbjct: 86 INLLGACEHRGYLYLAIEYAPHGNLLDFL 114
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 75 RLLGICLT-STVQLITQLMPFGCLLDYV 101
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 83 RLLGICLT-STVQLIMQLMPFGCLLDYV 109
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
D Q Y + N F + LG G FG T Y +D + VA+KML S+
Sbjct: 31 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ +E ++L + +H N+ +L+G C GG ++ EY YG+L +L
Sbjct: 91 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 11/111 (9%)
Query: 594 DNQQFTYSEIVDITNN---FHRILGKGGFG-----TVYHGYLADGS-EVAIKMLSASSSQ 644
D Q Y + N F + LG G FG T Y +D + VA+KML S+
Sbjct: 31 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 90
Query: 645 GPKQ-FRTEAQLLMRV-HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ +E ++L + +H N+ +L+G C GG ++ EY YG+L +L
Sbjct: 91 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 141
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV 107
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV 107
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV 107
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G FG V+ G ++VAIK L + P+ F EAQ++ ++ H L L ++
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ +V EYM G+L +L
Sbjct: 76 -EPIYIVTEYMNKGSLLDFL 94
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 83 RLLGICLT-STVQLITQLMPFGCLLDYV 109
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 18 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 78 RLLGICLT-STVQLITQLMPFGCLLDYV 104
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 84 RLLGICLT-STVQLITQLMPFGCLLDYV 110
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 84 RLLGICLT-STVQLITQLMPFGCLLDYV 110
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 46 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 106 RLLGICLT-STVQLITQLMPFGCLLDYV 132
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 27 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 87 RLLGICLT-STVQLITQLMPFGCLLDYV 113
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 84 RLLGICLT-STVQLITQLMPFGCLLDYV 110
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 83 RLLGICLT-STVQLITQLMPFGCLLDYV 109
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 16 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 74
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 75 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 104
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 88 RLLGICLT-STVQLITQLMPFGCLLDYV 114
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 36 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 31 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 31 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 88 RLLGICLT-STVQLITQLMPFGCLLDYV 114
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 25 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 84 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 24 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 83 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 22 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 81 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 110
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 612 RILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLA 665
R LG+G FG V + D G +VA+K L S + E ++L ++H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 666 SLVGYC-NDGGN-VGLVYEYMAYGNLKQYL 693
G C DGGN + L+ E++ G+LK+YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 24 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 83 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 21 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 110
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 18 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 77 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 25 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 82 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 114
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 29 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 86 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 118
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 18 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 77 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 21 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 79
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 80 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 109
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 25 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 84 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 612 RILGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLA 665
R LG+G FG V + D G +VA+K L S + E ++L ++H N+
Sbjct: 15 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 666 SLVGYC-NDGGN-VGLVYEYMAYGNLKQYL 693
G C DGGN + L+ E++ G+LK+YL
Sbjct: 75 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL 104
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 36 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
+F S + + +N + + +GKGGFG V+ G L D S VAIK L S+G
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
++F+ E ++ ++H N+ L G ++ +V E++ G+L L
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL 113
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 612 RILGKGGFGTVYHGYLADG-------SEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
R LG+G FG VY G +A G + VAIK ++ ++S + +F EA ++ + +
Sbjct: 53 RELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G + G ++ E M G+LK YL
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 28 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 85 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 117
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 36 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 36 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 93 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
+F S + + +N + + +GKGGFG V+ G L D S VAIK L S+G
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
++F+ E ++ ++H N+ L G ++ +V E++ G+L L
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL 113
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 43.9 bits (102), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 597 QFTYSEIVDITNN---FHRILGKGGFGTVYHGYLA-DGSEVAIKMLSASSSQGP------ 646
+F S + + +N + + +GKGGFG V+ G L D S VAIK L S+G
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 647 -KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
++F+ E ++ ++H N+ L G ++ +V E++ G+L L
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL 113
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 16/93 (17%)
Query: 614 LGKGGFGTVYHGYLADG-----------SEVAIKMLSASSSQGP-KQFRTEAQLLMRV-H 660
LG+G FG V LA+ ++VA+KML + +++ +E +++ +
Sbjct: 77 LGEGAFGQVV---LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 661 HRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
H+N+ +L+G C G + ++ EY + GNL++YL
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 43.5 bits (101), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
++G+G FG V +VAIK + + S + K F E + L RV+H N+ L G C
Sbjct: 15 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFG 695
+ V LV EY G+L L G
Sbjct: 72 LN--PVCLVMEYAEGGSLYNVLHG 93
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ +++H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 97 VRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 30/84 (35%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
++G+G FG V +VAIK + + S + K F E + L RV+H N+ L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 672 NDGGNVGLVYEYMAYGNLKQYLFG 695
+ V LV EY G+L L G
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLHG 92
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYL 178
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKMLSASSS-QGPKQFRTEAQLLMRVHHRNLA 665
++LG G FGTVY G ++ DG VAIK+L ++S + K+ EA ++ V ++
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V LV + M YG L ++
Sbjct: 83 RLLGICLT-STVQLVTQLMPYGCLLDHV 109
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+G C G + ++ EY + GNL++YL
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 17/133 (12%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
RL+ N H K G L++ TY ++ +D TN + +++G G FG V G
Sbjct: 4 RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 62
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
L S+ VAIK L ++ ++ F EA ++ + H N+ L G V +V
Sbjct: 63 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 122
Query: 681 YEYMAYGNLKQYL 693
EYM G+L +L
Sbjct: 123 TEYMENGSLDSFL 135
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 9 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 108
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 43.1 bits (100), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ +++H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/133 (28%), Positives = 58/133 (43%), Gaps = 17/133 (12%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNF-----------HRILGKGGFGTVYHG 625
RL+ N H K G L++ TY + + F +++G G FG V G
Sbjct: 6 RLHFGNGHLKLPG-LRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
L S+ VAIK L ++ ++ F EA ++ + H N+ L G V +V
Sbjct: 65 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYL 693
EYM G+L +L
Sbjct: 125 TEYMENGSLDSFL 137
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 26 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 86 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 125
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 42.7 bits (99), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 22/130 (16%)
Query: 578 LNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYL--ADGS--EV 633
L + + +K + QQFT R+LGKG FG+V L DGS +V
Sbjct: 5 LGISDELKEKLEDVLIPEQQFTLG----------RMLGKGEFGSVREAQLKQEDGSFVKV 54
Query: 634 AIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVG------LVYEYMA 685
A+KML A +S ++F EA + H ++A LVG G ++ +M
Sbjct: 55 AVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114
Query: 686 YGNLKQYLFG 695
+G+L +L
Sbjct: 115 HGDLHAFLLA 124
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 17/133 (12%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
RL+ N H K G L++ TY ++ +D TN + +++G G FG V G
Sbjct: 6 RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
L S+ VAIK L ++ ++ F EA ++ + H N+ L G V +V
Sbjct: 65 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYL 693
EYM G+L +L
Sbjct: 125 TEYMENGSLDSFL 137
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V EYM G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYL 119
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYC 671
+G+G FG V+ G L AD + VA+K + K +F EA++L + H N+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
+ +V E + G+ +L
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL 203
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYL 124
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 42.7 bits (99), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 2/82 (2%)
Query: 614 LGKGGFGTVYHGYL-ADGSEVAIKMLSASSSQGPK-QFRTEAQLLMRVHHRNLASLVGYC 671
+G+G FG V+ G L AD + VA+K + K +F EA++L + H N+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
+ +V E + G+ +L
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL 203
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 42.7 bits (99), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCND 673
LG G G V+ GY ++VA+K L S P F EA L+ ++ H+ L L
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 674 GGNVGLVYEYMAYGNLKQYL 693
+ ++ EYM G+L +L
Sbjct: 80 -EPIYIITEYMENGSLVDFL 98
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 42.7 bits (99), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ EY + GNL++YL
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYL 121
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 42.7 bits (99), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 97 VRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 42.7 bits (99), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 37 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 97 VRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 42.7 bits (99), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 43 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFL 131
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 53 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFL 141
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 63 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFL 151
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 42.4 bits (98), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFL 124
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 42.4 bits (98), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++L G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 21 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV 107
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 42.4 bits (98), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++L G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 88 RLLGICLT-STVQLIMQLMPFGCLLDYV 114
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 42.4 bits (98), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 96 VRCIGVSLQSLPRFILLELMAGGDLKSFL 124
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFL 139
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFL 165
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 42.4 bits (98), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 28 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 88 VRCIGVSLQSLPRFILLELMAGGDLKSFL 116
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 54 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFL 142
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKML-SASSSQGPKQFRTEAQLLMRVHHRNLA 665
++L G FGTVY G ++ +G + VAIK L A+S + K+ EA ++ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L+G C V L+ + M +G L Y+
Sbjct: 88 RLLGICLT-STVQLITQLMPFGCLLDYV 114
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 15/112 (13%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
G+++S +Q+ + R LGKG FG VY LA + +A+K+L + +
Sbjct: 1 GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
Q R E ++ + H N+ L GY +D V L+ EY G + + L
Sbjct: 53 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 104
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 14/93 (15%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
R LG+G FG V Y D G VA+K L A + GP+ ++ E +L ++H
Sbjct: 37 RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHE 93
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
++ G C D G ++ LV EY+ G+L+ YL
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL 126
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 15/112 (13%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
G+++S +Q+ + R LGKG FG VY LA + +A+K+L + +
Sbjct: 1 GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
Q R E ++ + H N+ L GY +D V L+ EY G + + L
Sbjct: 53 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL 104
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 6/111 (5%)
Query: 585 SKKEGSLKSDNQQFTYSEIVDITNNFHRI-LGKGGFGTVYHGY-LADGSEVAIKMLSASS 642
S +EG +SD ++ Y + N R+ LGKG +G VY G L++ +AIK +
Sbjct: 4 STEEGDCESDLLEYDY----EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 643 SQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
S+ + E L + H+N+ +G ++ G + + E + G+L L
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL 110
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 15/112 (13%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQ 644
G+++S +Q+ + R LGKG FG VY LA + +A+K+L + +
Sbjct: 1 GAMESKKRQWALEDF-----EIGRPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLE 52
Query: 645 GP---KQFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
Q R E ++ + H N+ L GY +D V L+ EY G + + L
Sbjct: 53 KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL 104
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + VA+K+L S + Q R E ++ +HH N+
Sbjct: 29 RPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNI 85
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L Y D + L+ EY G L + L
Sbjct: 86 LRLYNYFYDRRRIYLILEYAPRGELYKEL 114
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 41.6 bits (96), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 612 RILGKGGFGTVYHGYLA----DGS--EVAIKML-SASSSQGPKQFRTEAQLLMRVHHRNL 664
R LG G FG VY G ++ D S +VA+K L S Q F EA ++ + +H+N+
Sbjct: 51 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+G ++ E MA G+LK +L
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ Y + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYL 132
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
+G+G +G VY + G VA+K L A P E LL +HH N+ SL+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
+ + LV+E+M +LK+ L
Sbjct: 89 HSERCLTLVFEFME-KDLKKVL 109
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
R LG+G FG V Y D G VA+K L A GP+ ++ E +L ++H
Sbjct: 20 RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHE 76
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
++ G C D G ++ LV EY+ G+L+ YL
Sbjct: 77 HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 41/82 (50%), Gaps = 3/82 (3%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKM--LSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
+G+G +G VY + G VA+K L A P E LL +HH N+ SL+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
+ + LV+E+M +LK+ L
Sbjct: 89 HSERCLTLVFEFME-KDLKKVL 109
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHR 662
R LG+G FG V Y D G VA+K L A GP+ ++ E +L ++H
Sbjct: 20 RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHE 76
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
++ G C D G ++ LV EY+ G+L+ YL
Sbjct: 77 HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 31 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 88 LRLYGYFHDATRVYLILEYAPLGTVYREL 116
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 40 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 97 LRLYGYFHDATRVYLILEYAPLGTVYREL 125
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
+RILG+G FG VY G + + VA+K + K+ F +EA ++ + H ++
Sbjct: 12 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL---------FGIFLVNLHVC 704
L+G + ++ E YG L YL + L +L +C
Sbjct: 72 VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 119
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 40 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 96
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 97 LRLYGYFHDATRVYLILEYAPLGTVYREL 125
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 16 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 73 LRLYGYFHDATRVYLILEYAPLGTVYREL 101
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 13 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 69
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 70 LRLYGYFHDATRVYLILEYAPLGTVYREL 98
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 41/90 (45%), Gaps = 5/90 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLA----DGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
R++G G FG V G L VAIK L ++ ++ F EA ++ + H N
Sbjct: 46 KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L G G V +V E+M G L +L
Sbjct: 106 VVHLEGVVTRGKPVMIVIEFMENGALDAFL 135
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 15 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYREL 100
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 15 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYREL 100
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
+RILG+G FG VY G + + VA+K + K+ F +EA ++ + H ++
Sbjct: 28 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL---------FGIFLVNLHVC 704
L+G + ++ E YG L YL + L +L +C
Sbjct: 88 VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 135
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEA 653
+++ +DI+ +++G G FG V G+L + VAIK L S + + + F +EA
Sbjct: 26 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA 85
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V ++ E+M G+L +L
Sbjct: 86 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 125
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 5/90 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
R++G G FG V G L + VAIK L ++ ++ F EA ++ + H N
Sbjct: 25 TIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 84
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L G V +V EYM G+L +L
Sbjct: 85 IIHLEGVVTKSKPVMIVTEYMENGSLDTFL 114
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYL-ADGSE---VAIKMLSAS-SSQGPKQFRTEA 653
+++ +D++ ++G G FG V G L A G + VAIK L + + ++F +EA
Sbjct: 7 FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEA 66
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G + V ++ E+M G L +L
Sbjct: 67 SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 106
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 16 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 72
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 73 LRLYGYFHDATRVYLILEYAPLGTVYREL 101
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 15 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYREL 100
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 11 RPLGKGKFGNVY---LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 67
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 68 LRLYGYFHDATRVYLILEYAPLGTVYREL 96
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/100 (28%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYL-ADGSE---VAIKMLSAS-SSQGPKQFRTEA 653
+++ +D++ ++G G FG V G L A G + VAIK L + + ++F +EA
Sbjct: 9 FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G + V ++ E+M G L +L
Sbjct: 69 SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 108
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 19 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 76 LRLYGYFHDATRVYLILEYAPLGTVYREL 104
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/109 (26%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 610 FHRILGKGGFGTVYHG----YLADGSEVAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNL 664
+RILG+G FG VY G + + VA+K + K+ F +EA ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL---------FGIFLVNLHVC 704
L+G + ++ E YG L YL + L +L +C
Sbjct: 76 VKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 5/89 (5%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNL 664
+++G G FG V G L + VAIK L A + + + F +EA ++ + H N+
Sbjct: 33 IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L G V ++ EYM G+L +L
Sbjct: 93 IHLEGVVTKCKPVMIITEYMENGSLDAFL 121
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 612 RILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQGP---KQFRTEAQLLMRVHHRNLASL 667
R LGKG FG VY + + A+K+L + + Q R E ++ + H N+ L
Sbjct: 14 RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
GY +D V L+ EY G + + L
Sbjct: 74 YGYFHDSTRVYLILEYAPLGTVYREL 99
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 14 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 71 LRLYGYFHDATRVYLILEYAPLGTVYREL 99
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 19 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 75
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 76 LRLYGYFHDATRVYLILEYAPLGTVYREL 104
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 614 LGKGGFGTVYHGYLA--------DGSEVAIKMLSASSSQGP-KQFRTEAQLLMRV-HHRN 663
LG+G FG V + VA+KML +++ +E +++ + H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ +L+G C G + ++ Y + GNL++YL
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYL 132
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
F+ LG+G F ++ G + +EV +K+L + + F A ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++L G C G LV E++ +G+L YL
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 610 FHRILGKGGFGTVYHGYLAD--------GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
F+ LG+G F ++ G + +EV +K+L + + F A ++ ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++L G C G LV E++ +G+L YL
Sbjct: 72 KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL 103
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 18 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 75 LRLYGYFHDATRVYLILEYAPLGTVYREL 103
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 18 RPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 75 LRLYGYFHDATRVYLILEYAPLGTVYREL 103
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 18 RPLGKGKFGNVY---LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNI 74
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 75 LRLYGYFHDATRVYLILEYAPLGTVYREL 103
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 601 SEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKML-SASSSQGPKQFRTEAQ 654
S+ +DI+ +++G G FG V G+L + VAIK L S + + + F +EA
Sbjct: 1 SKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 60
Query: 655 LLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V ++ E+M G+L +L
Sbjct: 61 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 99
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHR 662
R LG+G FG V Y D G VA+K L GP+ ++ E ++L ++H
Sbjct: 15 RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHE 71
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
++ G C D G +V LV EY+ G+L+ YL
Sbjct: 72 HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 14/93 (15%)
Query: 612 RILGKGGFGTVYHGYLAD------GSEVAIKMLSASSSQGPK---QFRTEAQLLMRVHHR 662
R LG+G FG V Y D G VA+K L GP+ ++ E ++L ++H
Sbjct: 14 RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHE 70
Query: 663 NLASLVGYCNDGG--NVGLVYEYMAYGNLKQYL 693
++ G C D G +V LV EY+ G+L+ YL
Sbjct: 71 HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 5/90 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRN 663
+++G G FG V G L + VAIK L A + + + F +EA ++ + H N
Sbjct: 11 KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L G V ++ EYM G+L +L
Sbjct: 71 IIHLEGVVTKCKPVMIITEYMENGSLDAFL 100
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V E M G+L +L
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 5/89 (5%)
Query: 610 FHRILGKGGFGTVYHGYLADGSE----VAIKMLSAS-SSQGPKQFRTEAQLLMRVHHRNL 664
+++G G FG V G L + VAIK L A + + + F +EA ++ + H N+
Sbjct: 18 IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L G V ++ EYM G+L +L
Sbjct: 78 IHLEGVVTKCKPVMIITEYMENGSLDAFL 106
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGP---KQFRTEAQLLMRVHHRNL 664
R LGKG FG VY LA + +A+K+L + + Q R E ++ + H N+
Sbjct: 17 RPLGKGKFGNVY---LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 73
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L GY +D V L+ EY G + + L
Sbjct: 74 LRLYGYFHDATRVYLILEYAPLGTVYREL 102
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 40.0 bits (92), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 30/100 (30%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 600 YSEIVDITN-NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEA 653
+++ +D TN + +++G G FG V G L S+ VAIK L ++ ++ F EA
Sbjct: 9 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 654 QLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++ + H N+ L G V +V E M G+L +L
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 108
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 15/134 (11%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKS--DNQQFT-----YSEIVDITNN-------FHRILGK 616
KR+R ++ + +G++ S DN F Y + V+I ++ H LG
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 617 GGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG 675
G FG V+ A G+ A K + + R E Q + + H L +L D
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 676 NVGLVYEYMAYGNL 689
+ ++YE+M+ G L
Sbjct: 228 EMVMIYEFMSGGEL 241
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 17/133 (12%)
Query: 577 RLNVDNSHSKKEGSLKSDNQQFTY----------SEIVDITN-NFHRILGKGGFGTVYHG 625
RL+ N H K G L++ TY ++ +D TN + +++G G FG V G
Sbjct: 6 RLHFGNGHLKLPG-LRTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSG 64
Query: 626 YLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRNLASLVGYCNDGGNVGLV 680
L S+ VAIK L ++ ++ F EA ++ + H N+ L G V +V
Sbjct: 65 RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124
Query: 681 YEYMAYGNLKQYL 693
E M G+L +L
Sbjct: 125 TEXMENGSLDSFL 137
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 40.0 bits (92), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 15/134 (11%)
Query: 571 KRKRAARLNVDNSHSKKEGSLKS--DNQQFT-----YSEIVDITNN-------FHRILGK 616
KR+R ++ + +G++ S DN F Y + V+I ++ H LG
Sbjct: 2 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 61
Query: 617 GGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYCNDGG 675
G FG V+ A G+ A K + + R E Q + + H L +L D
Sbjct: 62 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 121
Query: 676 NVGLVYEYMAYGNL 689
+ ++YE+M+ G L
Sbjct: 122 EMVMIYEFMSGGEL 135
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 39.7 bits (91), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 25/145 (17%)
Query: 575 AARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEVA 634
+LN + +K L SD + EI TN +++G G FG V+ L + EVA
Sbjct: 12 GVKLNPLDDPNKVIKVLASDGKTGEQREIA-YTNC--KVIGNGSFGVVFQAKLVESDEVA 68
Query: 635 IKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVGYCNDGGN------VGLVYEYMA-- 685
IK + K+F+ E Q++ V H N+ L + G+ + LV EY+
Sbjct: 69 IKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 686 -------YGNLKQYLFGIFLVNLHV 703
Y LKQ + + L+ L++
Sbjct: 124 VYRASRHYAKLKQTM-PMLLIKLYM 147
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 39.7 bits (91), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 67 RHVNILLFMGY 77
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 39.7 bits (91), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
+ +I+G G G V +G L + VAIK L A ++ ++ F +EA ++ + H N
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L G G +V EYM G+L +L
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 62 RHVNILLFMGY 72
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 8 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 66 RHVNILLFMGY 76
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 78 RHVNILLFMGY 88
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 78 RHVNILLFMGY 88
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 62 RHVNILLFMGY 72
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 62 RHVNILLFMGY 72
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPKQ-FRTEAQLLMRVHHRN 663
+ +I+G G G V +G L + VAIK L A ++ ++ F +EA ++ + H N
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L G G +V EYM G+L +L
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 24 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 82 RHVNILLFMGY 92
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 31 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 89 RHVNILLFMGY 99
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 67 RHVNILLFMGY 77
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 6 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 64 RHVNILLFMGY 74
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 90 RHVNILLFMGY 100
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 39.3 bits (90), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 25/71 (35%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKML--SASSSQGPKQFRTEAQLLMRV 659
EI D + +G G FGTVY G +VA+KML +A + Q + F+ E +L +
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 660 HHRNLASLVGY 670
H N+ +GY
Sbjct: 90 RHVNILLFMGY 100
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 38.5 bits (88), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSAS----SSQGPKQFRTEAQLLMRVHHRN 663
R+LGKGG+G V+ G+ A+K+L + +++ + E +L V H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FGIFL 698
+ L+ GG + L+ EY++ G L L GIF+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 38.5 bits (88), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 612 RILGKGGFGTVYHGYLADGSEV----AIKMLSAS----SSQGPKQFRTEAQLLMRVHHRN 663
R+LGKGG+G V+ G+ A+K+L + +++ + E +L V H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNLKQYL--FGIFL 698
+ L+ GG + L+ EY++ G L L GIF+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
+LGKG +G VY G L++ +AIK + S+ + E L + H+N+ +G
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
++ G + + E + G+L L
Sbjct: 75 SENGFIKIFMEQVPGGSLSALL 96
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
LGKG FG+V + L D G+ VA+K L S + F+ E Q+L +H +
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYL 693
G G + LV EY+ G L+ +L
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFL 101
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 37.7 bits (86), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 3/82 (3%)
Query: 614 LGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGYC 671
LG G + TVY G G VA+K + S +G P E L+ + H N+ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 672 NDGGNVGLVYEYMAYGNLKQYL 693
+ + LV+E+M +LK+Y+
Sbjct: 73 HTENKLTLVFEFMD-NDLKKYM 93
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 37.7 bits (86), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
LGKG FG+V + L D G+ VA+K L S + F+ E Q+L +H +
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYL 693
G G ++ LV EY+ G L+ +L
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFL 104
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 37.7 bits (86), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 42/83 (50%), Gaps = 7/83 (8%)
Query: 614 LGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQ---FRTEAQLLMRVHHRNLASLVGY 670
+G G FGTVY G +VA+K+L P+Q FR E +L + H N+ +GY
Sbjct: 44 IGSGSFGTVYKGKWH--GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
N+ +V ++ +L ++L
Sbjct: 101 MTK-DNLAIVTQWCEGSSLYKHL 122
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 37.7 bits (86), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
LGKG FG+V + L D G+ VA+K L S + F+ E Q+L +H +
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYL 693
G G ++ LV EY+ G L+ +L
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFL 105
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 37.4 bits (85), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 12/107 (11%)
Query: 589 GSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHG-YLADGSE----VAIKMLSASSS 643
G++K + F +E+ + ++LG G FGTV+ G ++ +G V IK++ S
Sbjct: 1 GAMKVLARIFKETELRKL-----KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG 55
Query: 644 QGPKQFRTEAQLLM-RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+ Q T+ L + + H ++ L+G C G ++ LV +Y+ G+L
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSL 101
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 37.4 bits (85), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 614 LGKGGFGTV---YHGYLAD--GSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
LGKG FG+V + L D G+ VA+K L S + F+ E Q+L +H +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 669 GYCNDGG--NVGLVYEYMAYGNLKQYL 693
G G ++ LV EY+ G L+ +L
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL 117
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 37.4 bits (85), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQG--PKQFRTEAQLLMRVHHR 662
+ + RI LG+G +G VY +E VAIK + + P E LL + HR
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L + + L++EY A +LK+Y+
Sbjct: 94 NIIELKSVIHHNHRLHLIFEY-AENDLKKYM 123
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 37.4 bits (85), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 5/83 (6%)
Query: 614 LGKGGFGTVYHGY--LADGSEVAIKMLSASSSQG-PKQFRTEAQLLMRVHHRNLASLVGY 670
LG+G + TVY G L D VA+K + +G P E LL + H N+ +L
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 671 CNDGGNVGLVYEYMAYGNLKQYL 693
+ ++ LV+EY+ +LKQYL
Sbjct: 69 IHTEKSLTLVFEYLD-KDLKQYL 90
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 37.4 bits (85), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 46/84 (54%), Gaps = 7/84 (8%)
Query: 612 RILGKGGFGTVYHG-YLADGSE----VAIKMLSASSSQGPKQFRTEAQLLM-RVHHRNLA 665
++LG G FGTV+ G ++ +G V IK++ S + Q T+ L + + H ++
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNL 689
L+G C G ++ LV +Y+ G+L
Sbjct: 97 RLLGLC-PGSSLQLVTQYLPLGSL 119
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 37.0 bits (84), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 16/113 (14%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
+H KEG K+D QF ++LG+G FG V+ GS+ A+K+L
Sbjct: 11 THHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
++ + + RT E +L+ V+H + L G + L+ +++ G+L
Sbjct: 61 KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL 113
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 37.0 bits (84), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
++GKG FG VYHG EVAI+++ + K F+ E + H N+ +G
Sbjct: 40 LIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 671 CNDGGNVGLV 680
C ++ ++
Sbjct: 98 CMSPPHLAII 107
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 36.6 bits (83), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
R+LGKG FG V D G E A+K++S + E QLL ++ H N+
Sbjct: 31 QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNL 689
L + D G LV E G L
Sbjct: 89 XKLYEFFEDKGYFYLVGEVYTGGEL 113
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 36.6 bits (83), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
R+LGKG FG V D G E A+K++S + E QLL ++ H N+
Sbjct: 31 QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNL 689
L + D G LV E G L
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL 113
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 36.6 bits (83), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 41/89 (46%), Gaps = 4/89 (4%)
Query: 609 NFHRILGKGGFGTVYHG-YLADGSEVAIKMLSASS--SQGPKQFRTEAQLLMRVHHRNLA 665
H +G GGF V ++ G VAIK++ ++ S P+ +TE + L + H+++
Sbjct: 13 ELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPR-IKTEIEALKNLRHQHIC 71
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
L + +V EY G L Y+
Sbjct: 72 QLYHVLETANKIFMVLEYCPGGELFDYII 100
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 36.6 bits (83), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 16/113 (14%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
+H KEG K+D QF ++LG+G FG V+ GS+ A+K+L
Sbjct: 11 THHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
++ + + RT E +L+ V+H + L G + L+ +++ G+L
Sbjct: 61 KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL 113
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 36.6 bits (83), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 30/113 (26%), Positives = 53/113 (46%), Gaps = 16/113 (14%)
Query: 583 SHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSEV----AIKML 638
+H KEG K+D QF ++LG+G FG V+ GS+ A+K+L
Sbjct: 12 THHVKEGHEKADPSQF----------ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 61
Query: 639 SASSSQGPKQFRT--EAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
++ + + RT E +L+ V+H + L G + L+ +++ G+L
Sbjct: 62 KKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL 114
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 36.2 bits (82), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 38/79 (48%), Gaps = 1/79 (1%)
Query: 612 RILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
ILG G FG V+ A G ++A K++ + ++ + E ++ ++ H NL L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 671 CNDGGNVGLVYEYMAYGNL 689
++ LV EY+ G L
Sbjct: 155 FESKNDIVLVMEYVDGGEL 173
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 36.2 bits (82), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F +I G+G GTVY +A G EVAI+ ++ Q PK+ ++L+ ++N ++V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNL 689
Y + G + +V EY+A G+L
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F +I G+G GTVY +A G EVAI+ ++ Q PK+ ++L+ ++N ++V
Sbjct: 26 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN-PNIV 81
Query: 669 GYCND---GGNVGLVYEYMAYGNL 689
Y + G + +V EY+A G+L
Sbjct: 82 NYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
R+LGKG FG V D G E A+K++S + E QLL ++ H N+
Sbjct: 37 QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNL 689
L + D G LV E G L
Sbjct: 95 MKLYEFFEDKGYFYLVGEVYTGGEL 119
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F +I G+G GTVY +A G EVAI+ ++ Q PK+ ++L+ ++N ++V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNL 689
Y + G + +V EY+A G+L
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 36.2 bits (82), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F +I G+G GTVY +A G EVAI+ ++ Q PK+ ++L+ ++N ++V
Sbjct: 26 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN-PNIV 81
Query: 669 GYCND---GGNVGLVYEYMAYGNL 689
Y + G + +V EY+A G+L
Sbjct: 82 NYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 36.2 bits (82), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 610 FHRILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLV 668
F +I G+G GTVY +A G EVAI+ ++ Q PK+ ++L+ ++N ++V
Sbjct: 25 FEKI-GQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKN-PNIV 80
Query: 669 GYCND---GGNVGLVYEYMAYGNL 689
Y + G + +V EY+A G+L
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 36.2 bits (82), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNL 664
R LGKG FG V YLA + +A+K+L S + Q R E ++ + H N+
Sbjct: 20 RPLGKGKFGNV---YLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ Y +D + L+ E+ G L + L
Sbjct: 77 LRMYNYFHDRKRIYLMLEFAPRGELYKEL 105
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 35.8 bits (81), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNL 664
R LGKG FG V YLA + +A+K+L S + Q R E ++ + H N+
Sbjct: 20 RPLGKGKFGNV---YLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ Y +D + L+ E+ G L + L
Sbjct: 77 LRMYNYFHDRKRIYLMLEFAPRGELYKEL 105
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 35.8 bits (81), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 612 RILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQG---PKQFRTEAQLLMRVHHRNL 664
R LGKG FG V YLA + +A+K+L S + Q R E ++ + H N+
Sbjct: 21 RPLGKGKFGNV---YLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 77
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ Y +D + L+ E+ G L + L
Sbjct: 78 LRMYNYFHDRKRIYLMLEFAPRGELYKEL 106
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 35.8 bits (81), Expect = 0.087, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
R+LGKG FG V D G E A+K++S + E QLL ++ H N+
Sbjct: 54 QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNL 689
L + D G LV E G L
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGEL 136
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 35.4 bits (80), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 37/85 (43%), Gaps = 8/85 (9%)
Query: 611 HRILGKGGFGTVYHGYLAD---GSEVAIKMLS---ASSSQGPKQFRTEAQLLMRVHHRNL 664
R+LGKG FG V D G E A+K++S + E QLL ++ H N+
Sbjct: 55 QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 665 ASLVGYCNDGGNVGLVYEYMAYGNL 689
L + D G LV E G L
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGEL 137
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 610 FHRILGKGGFGTVYH-GYLADGSEVAIKMLSASSSQGP-KQFRTEAQLLMRVHHRNLASL 667
F R LG G FG V+ + G E IK ++ SQ P +Q E ++L + H N+ +
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 668 VGYCNDGGNVGLVYEYMAYGNL 689
D N+ +V E G L
Sbjct: 86 FEVFEDYHNMYIVMETCEGGEL 107
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 574 RAARLNVDNSHSKKEGSLKSDNQQFTYSEIVDITNNFHRILGKGGFGTVYHGYLADGSE- 632
R ++++ D SK + + Q + V T+ +++G G FG VY L D E
Sbjct: 2 RGSKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT--KVIGNGSFGVVYQAKLCDSGEL 59
Query: 633 VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 60 VAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 90
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 35.4 bits (80), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA+K++ + SS K FR E +++ ++H N+ L
Sbjct: 13 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 71
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 72 FEVIETEKTLYLVMEYASGGEVFDYL 97
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 35.0 bits (79), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA+K++ + SS K FR E +++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYL 104
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 35.0 bits (79), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA+K++ + SS K FR E +++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYL 104
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
EI + + LG G FG V+ ++VA+K + S + F EA ++ + H
Sbjct: 11 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQH 69
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L L + ++ E+MA G+L +L
Sbjct: 70 DKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL 100
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA+K++ + SS K FR E +++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYL 104
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 34.3 bits (77), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
EI + + LG G FG V+ ++VA+K + S + F EA ++ + H
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQH 236
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L L + ++ E+MA G+L +L
Sbjct: 237 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 267
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 34.3 bits (77), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA++++ + SS K FR E +++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYL 104
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 34.3 bits (77), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 26/96 (27%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 603 IVDITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLM 657
+VD+ NF ++ +G+G +G VY G VA+K L + P E LL
Sbjct: 3 LVDM-ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 658 RVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
++H N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 33.9 bits (76), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 43/86 (50%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA++++ + SS K FR E +++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYL 104
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 24/92 (26%), Positives = 41/92 (44%), Gaps = 2/92 (2%)
Query: 602 EIVDITNNFHRILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHH 661
EI + + LG G FG V+ ++VA+K + S + F EA ++ + H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQH 242
Query: 662 RNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L L + ++ E+MA G+L +L
Sbjct: 243 DKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 273
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 18/59 (30%), Positives = 34/59 (57%), Gaps = 3/59 (5%)
Query: 613 ILGKGGFGTVYHG-YLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV-HHRNLASLVG 669
++G G +G VY G ++ G AIK++ + + ++ + E +L + HHRN+A+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 88
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
+F +LG G F V LA+ VAIK ++ + +G + E +L ++ H N
Sbjct: 21 DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNL 689
+ +L GG++ L+ + ++ G L
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV 659
+ NF ++ +G+G +G VY G VA+K L + P E LL +
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+H N+ L+ + + LV+E++ + +LK+++
Sbjct: 67 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 33.9 bits (76), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
+F +LG G F V LA+ VAIK ++ + +G + E +L ++ H N
Sbjct: 21 DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNL 689
+ +L GG++ L+ + ++ G L
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 33.9 bits (76), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSAS---SSQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVA+K++ + SS K FR E ++ ++H N+ L
Sbjct: 20 KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKL 78
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ LV EY + G + YL
Sbjct: 79 FEVIETEKTLYLVXEYASGGEVFDYL 104
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 33.9 bits (76), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
+F +LG G F V LA+ VAIK ++ + +G + E +L ++ H N
Sbjct: 21 DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNL 689
+ +L GG++ L+ + ++ G L
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 33.9 bits (76), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 24/94 (25%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 605 DITNNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRV 659
+ NF ++ +G+G +G VY G VA+K L + P E LL +
Sbjct: 7 EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 660 HHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+H N+ L+ + + LV+E++ + +LK+++
Sbjct: 67 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 54 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 106
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 34 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 86
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 24/34 (70%), Gaps = 1/34 (2%)
Query: 613 ILGKGGFGTVYHGY-LADGSEVAIKMLSASSSQG 645
+LGKGGFGTV+ G+ L D +VAIK++ + G
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 45 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 97
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 38 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 90
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 39 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 91
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + QG K F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRL 78
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 78
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 78
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 27 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 79
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 65 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 62 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 114
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 112
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 112
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 78
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + QG K F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRL 78
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 78
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 32/58 (55%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + QG K F+ E Q++ ++ H N+ L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIVRL 78
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 65 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 33.5 bits (75), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 64 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 116
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 33.5 bits (75), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 33.5 bits (75), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 65 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 33.5 bits (75), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 33.5 bits (75), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E+++ +LK+++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFLSM-DLKKFM 95
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 33.5 bits (75), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E+++ +LK+++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFLSM-DLKKFM 93
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 33.5 bits (75), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 31 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 83
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 33.5 bits (75), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 30 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 82
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 33.1 bits (74), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 8/86 (9%)
Query: 609 NFHRILGKGGFGTVYHGYLADGSE----VAIKMLSASSSQGPK-QFRTEAQLLMRVHHRN 663
+F +LG G F V LA+ VAIK ++ + +G + E +L ++ H N
Sbjct: 21 DFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNL 689
+ +L GG++ L+ + ++ G L
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 33.1 bits (74), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFRT-EAQLLMRVHHRNLASL 667
+++G G FG VY L D E VAIK + K+F+ E Q++ ++ H N+ L
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRL 157
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 33.1 bits (74), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 33.1 bits (74), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 33.1 bits (74), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 33.1 bits (74), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK ++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKDFM 92
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 32.7 bits (73), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 610 FHRILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLA 665
+ +GKG F V ++ G EVA+K++ + + K FR E +++ ++H N+
Sbjct: 19 LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 666 SLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
L + LV EY + G + YL
Sbjct: 78 KLFEVIETEKTLYLVMEYASGGEVFDYL 105
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 15/32 (46%), Positives = 23/32 (71%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
+G+IP+FLSQ+ L L+ N LSG++P S+
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Score = 31.6 bits (70), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 22/31 (70%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTS 513
+G++P +S LP L + DGN++SG++P S
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 32.7 bits (73), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E+++ +LK ++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFLSM-DLKDFM 95
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 32.7 bits (73), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 5 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E+++ +LK ++
Sbjct: 65 NIVKLLDVIHTENKLYLVFEFLSM-DLKDFM 94
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 32.7 bits (73), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVAIK++ + + K FR E +++ ++H N+ L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL 79
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+ EY + G + YL
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL 105
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 612 RILGKGGFGTVYHG-YLADGSEVAIKMLSASS---SQGPKQFRTEAQLLMRVHHRNLASL 667
+ +GKG F V ++ G EVAIK++ + + K FR E +++ ++H N+ L
Sbjct: 18 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL 76
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ L+ EY + G + YL
Sbjct: 77 FEVIETEKTLYLIMEYASGGEVFDYL 102
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 34/76 (44%), Gaps = 4/76 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
R +G G FG VY SE VAIK +S S Q ++++ E + L ++ H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 668 VGYCNDGGNVGLVYEY 683
G LV EY
Sbjct: 81 RGCYLREHTAWLVMEY 96
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 32.3 bits (72), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK ++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFL-HQDLKTFM 95
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 32.3 bits (72), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 26/104 (25%), Positives = 50/104 (48%), Gaps = 8/104 (7%)
Query: 594 DNQQFTYSEIVDITNNFHR--ILGKGGFGTVYHGYLADGSEV-AIKMLSASSSQ--GPK- 647
+N F ++++ +H +G+G +G V + AIK+++ + + PK
Sbjct: 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 648 --QFRTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNL 689
+ +TE +L+ ++HH N+A L D + LV E G+L
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL 115
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 32.3 bits (72), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/76 (32%), Positives = 34/76 (44%), Gaps = 4/76 (5%)
Query: 612 RILGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQFR---TEAQLLMRVHHRNLASL 667
R +G G FG VY SE VAIK +S S Q ++++ E + L ++ H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 668 VGYCNDGGNVGLVYEY 683
G LV EY
Sbjct: 120 RGCYLREHTAWLVMEY 135
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 606 ITNNFHRILGKGGFGTVYHGYLADGS----EVAIKML---SASSSQGPKQFRTEAQLLMR 658
I N ++I+ K G G + YLA+ + +VAIK + + K+F E +
Sbjct: 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 659 VHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
+ H+N+ S++ + LV EY+ L +Y+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVA--IKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY EV K+ + ++G P E LL ++H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/91 (25%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGYLADGSEVA--IKMLSASSSQG-PKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY EV K+ + ++G P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK+++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 18/79 (22%), Positives = 35/79 (44%), Gaps = 1/79 (1%)
Query: 613 ILGKGGFG-TVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASLVGYC 671
+LGKG FG + + G + +K L + + F E +++ + H N+ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 672 NDGGNVGLVYEYMAYGNLK 690
+ + EY+ G L+
Sbjct: 77 YKDKRLNFITEYIKGGTLR 95
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
R+LG+GGFG V+ + A G A +G + E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFGI 696
++ LV M G+++ +++ +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 22/34 (64%), Gaps = 3/34 (8%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKML 638
N+F HRI+G+GGFG VY AD G A+K L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 22/34 (64%), Gaps = 3/34 (8%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKML 638
N+F HRI+G+GGFG VY AD G A+K L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
R+LG+GGFG V+ + A G A +G + E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFGI 696
++ LV M G+++ +++ +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 22/34 (64%), Gaps = 3/34 (8%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKML 638
N+F HRI+G+GGFG VY AD G A+K L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
R+LG+GGFG V+ + A G A +G + E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFGI 696
++ LV M G+++ +++ +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 22/34 (64%), Gaps = 3/34 (8%)
Query: 608 NNF--HRILGKGGFGTVYHGYLAD-GSEVAIKML 638
N+F HRI+G+GGFG VY AD G A+K L
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 221
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 32.0 bits (71), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 612 RILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
R+LG+GGFG V+ + A G A +G + E ++L +VH R + SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 668 VGYCNDGGNVGLVYEYMAYGNLKQYLFGI 696
++ LV M G+++ +++ +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ + +LK ++
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM 91
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 31.6 bits (70), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 597 QFTYSEIVDITNNF---HRILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQF 649
Q+ + E +T N +R+LGKGGFG V + A G A + +G
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
E Q+L +V+ R + SL + LV M G+LK +++
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 276
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 31.6 bits (70), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 597 QFTYSEIVDITNNF---HRILGKGGFGTVYHGYL-ADGSEVAI---KMLSASSSQGPKQF 649
Q+ + E +T N +R+LGKGGFG V + A G A + +G
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 650 RTEAQLLMRVHHRNLASLVGYCNDGGNVGLVYEYMAYGNLKQYLF 694
E Q+L +V+ R + SL + LV M G+LK +++
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 276
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 31.6 bits (70), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 3/64 (4%)
Query: 610 FHRILGKGGFGTV--YHGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRVHHRNLASL 667
F + LG+GGF V G L DG A+K + Q ++ + EA + +H N+ L
Sbjct: 33 FIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 668 VGYC 671
V YC
Sbjct: 92 VAYC 95
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 31.2 bits (69), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 6/77 (7%)
Query: 614 LGKGGFGTVYHGYLADGSE-VAIKMLSASSSQGPKQF--RT---EAQLLMRVHHRNLASL 667
LG+G F TVY + ++ VAIK + K RT E +LL + H N+ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 668 VGYCNDGGNVGLVYEYM 684
+ N+ LV+++M
Sbjct: 78 LDAFGHKSNISLVFDFM 94
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 31.2 bits (69), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 3/77 (3%)
Query: 613 ILGKGGFGTVYHGYLAD-GSEVAIK-MLSASSSQGPKQFRT-EAQLLMRVHHRNLASLVG 669
++G+G +G V D G VAIK L + + K+ E +LL ++ H NL +L+
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 670 YCNDGGNVGLVYEYMAY 686
C LV+E++ +
Sbjct: 92 VCKKKKRWYLVFEFVDH 108
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 11/88 (12%)
Query: 613 ILGKGGFGTVYHGYLADGSEVAIKMLSASSSQGPKQFRTEAQL--LMRVHHRNLAS-LVG 669
++G+G +G VY G L D VA+K+ S ++ Q F E + + + H N+A +VG
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVG 75
Query: 670 ---YCNDGG-NVGLVYEYMAYGNLKQYL 693
DG LV EY G+L +YL
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYL 103
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 608 NNFHRI--LGKGGFGTVYHGY-LADGSEVAIK--MLSASSSQGPKQFRTEAQLLMRVHHR 662
NF ++ +G+G +G VY G VA+K L + P E LL ++H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 663 NLASLVGYCNDGGNVGLVYEYMAYGNLKQYL 693
N+ L+ + + LV+E++ +LK+++
Sbjct: 66 NIVKLLDVIHTENKLYLVFEHVD-QDLKKFM 95
>pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle
Checkpoint Kinase Bub
Length = 365
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 611 HRILGKGGFGTVY---HGYLADGSEVAIKMLSASSSQGPKQFRTEAQLLMRV----HHRN 663
H +LG+G F VY G L D +L P +F QL+ R+ H
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 664 LASLVGYCNDGGNVGLVYEYMAYGNL 689
+ + G+V LV E +YG L
Sbjct: 130 MKFYSAHLFQNGSV-LVGELYSYGTL 154
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 9/85 (10%)
Query: 436 LNCSYN---GYKP------PKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSI 486
L+ SYN GY P P + LNL ++G I G I
Sbjct: 634 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 693
Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVP 511
P+ +S L +L ++L N LSG +P
Sbjct: 694 PQAMSALTMLTEIDLSNNNLSGPIP 718
Score = 30.0 bits (66), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 14/34 (41%), Positives = 22/34 (64%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVA 516
+GSIP+ + L L +L+L NKL G +P ++ A
Sbjct: 666 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 699
Score = 29.6 bits (65), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 13/32 (40%), Positives = 20/32 (62%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
TG IP+++ +L L +L L N SG++P L
Sbjct: 500 TGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 531
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 30.0 bits (66), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 35/85 (41%), Gaps = 9/85 (10%)
Query: 436 LNCSYN---GYKP------PKIISLNLTSEGLTGKIXXXXXXXXXXXXXXXXXXXXTGSI 486
L+ SYN GY P P + LNL ++G I G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696
Query: 487 PEFLSQLPLLRVLNLDGNKLSGSVP 511
P+ +S L +L ++L N LSG +P
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIP 721
Score = 29.6 bits (65), Expect = 5.4, Method: Compositional matrix adjust.
Identities = 14/34 (41%), Positives = 22/34 (64%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSLVA 516
+GSIP+ + L L +L+L NKL G +P ++ A
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Score = 29.3 bits (64), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 13/32 (40%), Positives = 20/32 (62%)
Query: 483 TGSIPEFLSQLPLLRVLNLDGNKLSGSVPTSL 514
TG IP+++ +L L +L L N SG++P L
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 30.0 bits (66), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 3/79 (3%)
Query: 614 LGKGGFG-TVYHGYLADGSEVAIKMLSAS--SSQGPKQFRTEAQLLMRVHHRNLASLVGY 670
+G+G FG + DG + IK ++ S SS+ ++ R E +L + H N+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 671 CNDGGNVGLVYEYMAYGNL 689
+ G++ +V +Y G+L
Sbjct: 92 FEENGSLYIVMDYCEGGDL 110
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.135 0.401
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 19,868,917
Number of Sequences: 62578
Number of extensions: 801254
Number of successful extensions: 2528
Number of sequences better than 100.0: 499
Number of HSP's better than 100.0 without gapping: 191
Number of HSP's successfully gapped in prelim test: 308
Number of HSP's that attempted gapping in prelim test: 2147
Number of HSP's gapped (non-prelim): 524
length of query: 710
length of database: 14,973,337
effective HSP length: 106
effective length of query: 604
effective length of database: 8,340,069
effective search space: 5037401676
effective search space used: 5037401676
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 55 (25.8 bits)